1st Quarter - Report — AMERICAN OSTEOPATHIC ASSOCIATION for AMERICAN OSTEOPATHIC ASSOCIATION (2021)

Firm

AMERICAN OSTEOPATHIC ASSOCIATION

Client

AMERICAN OSTEOPATHIC ASSOCIATION

Income

—

Expenses

$213,236

Expense method

B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

8 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

US House of Representatives, US Senate, CMS, EOP, HHS, MedPAC, White House Office

Lobbyist	Covered position, as disclosed
MARK LUKASZEWSKI	Associate Director, Congressional Affairs
DAVID PUGACH	Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA	Sr. Director of Congressional Affairs

Contacted: Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC); Executive Office of the President (EOP); Government Accountability Office (GAO); Office of Management & Budget (OMB); SENATE; Agency for Healthcare Research & Quality (AHRQ); White House Office; Health & Human Services, Dept of (HHS); Health Resources & Services Administration (HRSA); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Medicare Payment Advisory Commission (MedPAC)

Medical/Disease Research/Clinical Labs MED

US House of Representatives, US Senate, HHS, HRSA, AHRQ

Lobbyist	Covered position, as disclosed
MARK LUKASZEWSKI	Associate Director, Congressional Affairs
DAVID PUGACH	Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA	Sr. Director of Congressional Affairs

Contacted: Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); Agency for Healthcare Research & Quality (AHRQ); Centers For Disease Control & Prevention (CDC); SENATE; Office of Management & Budget (OMB); Medicare Payment Advisory Commission (MedPAC); Food & Drug Administration (FDA); Government Accountability Office (GAO); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Health Resources & Services Administration (HRSA); White House Office

Taxation/Internal Revenue Code TAX

US HOuse of Representatives, US Senate

Lobbyist	Covered position, as disclosed
MARK LUKASZEWSKI	Associate Director, Congressional Affairs
DAVID PUGACH	Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA	Sr. Director of Congressional Affairs

Contacted: Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); Medicare Payment Advisory Commission (MedPAC); Centers For Disease Control & Prevention (CDC); Agency for Healthcare Research & Quality (AHRQ); Government Accountability Office (GAO); Health & Human Services, Dept of (HHS); SENATE; White House Office; HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Health Resources & Services Administration (HRSA); Food & Drug Administration (FDA)

Health Issues HCR

US House of Representatives, HHS, HRSA, White House Office, CDC, CMS, FDA, GAO, OMB, EOP

Lobbyist	Covered position, as disclosed
MARK LUKASZEWSKI	Associate Director, Congressional Affairs
DAVID PUGACH	Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA	Sr. Director of Congressional Affairs

Contacted: Government Accountability Office (GAO); Office of Management & Budget (OMB); Agency for Healthcare Research & Quality (AHRQ); SENATE; Health Resources & Services Administration (HRSA); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Medicare Payment Advisory Commission (MedPAC); Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); White House Office

Budget/Appropriations BUD

US House of Representatives, US Senate, HHS, HRSA

Lobbyist	Covered position, as disclosed
MARK LUKASZEWSKI	Associate Director, Congressional Affairs
DAVID PUGACH	Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA	Sr. Director of Congressional Affairs

Contacted: Agency for Healthcare Research & Quality (AHRQ); Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS); SENATE; Government Accountability Office (GAO); Centers For Medicare and Medicaid Services (CMS); White House Office; Medicare Payment Advisory Commission (MedPAC); Food & Drug Administration (FDA); Office of Management & Budget (OMB); Executive Office of the President (EOP); Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES

Insurance INS

US House of Representatives, US Senate, EOP, HHS, CMS

Lobbyist	Covered position, as disclosed
MARK LUKASZEWSKI	Associate Director, Congressional Affairs
DAVID PUGACH	Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA	Sr. Director of Congressional Affairs

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Agency for Healthcare Research & Quality (AHRQ); Food & Drug Administration (FDA); Office of Management & Budget (OMB); SENATE; Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); Health Resources & Services Administration (HRSA); Executive Office of the President (EOP); Government Accountability Office (GAO); Medicare Payment Advisory Commission (MedPAC); White House Office

Education EDU

US House of Representatives, US Senate

Lobbyist	Covered position, as disclosed
MARK LUKASZEWSKI	Associate Director, Congressional Affairs
DAVID PUGACH	Sr. VP Public Policy
JOHN MICHAEL C. VILLARAMA	Sr. Director of Congressional Affairs

Contacted: White House Office; Agency for Healthcare Research & Quality (AHRQ); Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Government Accountability Office (GAO); Office of Management & Budget (OMB); Medicare Payment Advisory Commission (MedPAC); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA); SENATE

Torts TOR

US House of Representatives, US Senate

Lobbyist	Covered position, as disclosed
MARK LUKASZEWSKI	Associate Director, Congressional Affairs
DAVID PUGACH	Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA	Sr. Director of Congressional Affairs

Contacted: Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Medicare Payment Advisory Commission (MedPAC); White House Office; SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Health Resources & Services Administration (HRSA); Centers For Disease Control & Prevention (CDC); Agency for Healthcare Research & Quality (AHRQ); Government Accountability Office (GAO)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.